{"nct_id":"NCT05118789","title":"A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)","status":"RECRUITING","status_verified_date":"2025-07","start_date":"2022-01-04","start_date_type":"ACTUAL","primary_completion_date":"2025-10-31","primary_completion_date_type":"ESTIMATED","completion_date":"2026-10-31","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["NUVL"]}